CSN3 and Parkinson disease: By using pharmacological inhibitors and activators, Dolga and colleagues found that SK/KCa channels participated in the pathological process of stroke, Parkinson’s disease (PD), Alzheimer’s disease (AD) and schizophrenia (Anderson et al., 2006; Dolga et al., 2011, 2012; Dolga and Culmsee, 2012).